Literature DB >> 10783389

Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3.

R Fujii1, M Hosoya, S Fukusumi, Y Kawamata, Y Habata, S Hinuma, H Onda, O Nishimura, M Fujino.   

Abstract

Neuromedin U is a bioactive peptide first isolated from porcine spinal cord. In this paper, we demonstrate that neuromedin U is the cognate ligand for the orphan G protein-coupled receptor, FM-3, isolated originally as a homologue of neurotensin and growth hormone secretogogue receptors. Neuromedin U induced specific and evident elevation of extracellular acidification rates, arachidonic acid metabolite release, and intracellular Ca(2+) mobilization in Chinese hamster ovary cells expressing human FM-3. In addition, radiolabeled neuromedin U specifically bound to membrane fractions prepared from these cells with high affinity. We subsequently analyzed the tissue distribution of neuromedin U and FM-3 mRNAs in rats using quantitative reverse transcription-polymerase chain reaction. Neuromedin U mRNA was highly expressed in the gastrointestinal tract, and the highest expression was detected in the pituitary gland. On the other hand, FM-3 mRNA was highly expressed in the small intestine and lung, suggesting that neuromedin U plays important roles in these tissues. The identification of a specific and functional receptor for neuromedin U will facilitate studies on their physiological roles and the search for receptor agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783389     DOI: 10.1074/jbc.M001546200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 2.  Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors:  Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  Identification of functionally important residues of the silkmoth pheromone biosynthesis-activating neuropeptide receptor, an insect ortholog of the vertebrate neuromedin U receptor.

Authors:  Takeshi Kawai; Yukie Katayama; Linjun Guo; Desheng Liu; Tatsuya Suzuki; Kou Hayakawa; Jae Min Lee; Toshihiro Nagamine; J Joe Hull; Shogo Matsumoto; Hiromichi Nagasawa; Masaru Tanokura; Koji Nagata
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

4.  Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Authors:  T Kaisho; H Nagai; T Asakawa; N Suzuki; H Fujita; K Matsumiya; N Nishizawa; Y Kanematsu-Yamaki; K Dote; J-I Sakamoto; T Asami; S Takekawa
Journal:  Int J Obes (Lond)       Date:  2017-07-31       Impact factor: 5.095

5.  Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.

Authors:  N B Dass; A K Bassil; V J North-Laidler; R Morrow; E Aziz; B R Tuladhar; G J Sanger
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

6.  Identification of G protein-coupled receptors for Drosophila PRXamide peptides, CCAP, corazonin, and AKH supports a theory of ligand-receptor coevolution.

Authors:  Yoonseong Park; Young-Joon Kim; Michael E Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 7.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

8.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

9.  The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).

Authors:  Andrea Peier; Jennifer Kosinski; Kimberly Cox-York; Ying Qian; Kunal Desai; Yue Feng; Prashant Trivedi; Nicholas Hastings; Donald J Marsh
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

10.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.